Tuesday, 23 June 2026
  
Login

Australia's most trusted
source of pharma news

Tuesday, 23 June 2026
News

Mega pays are not just for CEOs

Posted 23 June 2026 PM

Who says you have to be a CEO to make megabucks? Ten scientists and doctors in biopharma companies received pay packages worth more than US$10 million ($14.2 million) each last year.

Top of the list was Eli Lilly Chief Scientific and Product Officer Dan Skovronsky, who made US$17,786,576, including US$1.49 million in salary, a US$3.25 million bonus, and US$12 million in stock awards, according to Endpoints News, which analysed data from hundreds of publicly traded pharma and biotech companies to compile the pay report.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (2)

Sales & Customer Relations (20)

Access & Reimbursement (2)

Clinical & Medical, R&D (8)

Regulatory, Pharmacovigilance & QA (6)

Other (8)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.